How to relieve tumor lysis syndrome caused by Venetoclax?

Venetoclax/Venetoclax (Venetoclax) may cause tumor lysis syndrome (Tumor Lysis Syndrome, TLS), which is a symptom of electrolyte imbalance caused by intracellular components released by the death of a large number of tumor cells into the blood. TLScan pose serious threats to the kidneys, heart, and other organs, so mitigation measures are needed.

The following are common ways to relieve tumor lysis syndrome caused by venetoclax/venetoclax:

1.Adequate fluid intake: Venetoclax/VenetoclaxDuring treatment, increasing the patient's water intake is the key to preventing the occurrence of TLS. Adequate water can help dilute intracellular components released in the blood and slow down their impact on the kidneys. Doctors often advise patients to drink more fluids and may consider intravenous fluids to ensure adequate fluid intake.

2.Electrolyte monitoring and adjustment: TLSis usually accompanied by electrolyte abnormalities, such as high potassium, high phosphorus, high uric acid, etc. Doctors will regularly monitor patients' electrolyte levels and take appropriate measures as needed, such as using medications to adjust electrolyte levels.

3.Urine acid-base balance: Urine acid-base balance is a key link in TLS management. Alkalizing urine slows the formation and deposition of uric acid, helping to prevent urinary tract obstruction and kidney damage. Alkalinization is usually accomplished with oral alkaline agents or intravenous alkalinization.

4.Use of diuretics: Diuretics can increase urine excretion and help remove metabolites from the body. However, care needs to be taken to avoid excessive dehydration when using diuretics, so they are usually used only when appropriate.

5.Symptomatic treatment: IfTLS has occurred, the doctor may take some symptomatic treatment measures, such as using drugs to correct electrolyte abnormalities, protect kidney function, and closely monitor the patient's condition changes.

6.AdjustVenetoclax/VenetoclaxDosage: In patients who are at higher risk for TLS, physicians may consider adjusting the initial dose of venetoclax or slowly titrating the dose to reduce the patient's risk of developing TLS when starting treatment.

Patients should receive regular medical monitoring during treatment with venetoclax/venetoclax. The medical team will pay close attention to the patient's biochemical indicators, urinalysis and other related parameters. Patients need to closely follow their doctors' advice and promptly report any symptoms of discomfort to ensure thatTLS is prevented and treated promptly. Although the occurrence of TLS is relatively rare, effective monitoring and intervention during venetoclax/venetoclax treatment will help to minimize patient discomfort and risk.

Venetoclax/Venetoclax has been launched in China and has been included in medical insurance, and patients can purchase it domestically. Specifications: 100mg*14tablets and the price is around 5,000yuan. Please consult the local hospital pharmacy for specific prices. There are original drugs and generic drugs abroad. The Turkish version of Venetoclax/Venetoclaxoriginal drug on the market overseas, specification: 100mg*112 tablets, costs about 10,000 per box. Foreign generic drugs are relatively cheaper. For example, the generic drugs sold in Laos and Bangladesh are priced at about more than 4,000 yuan for 100mg*120 tablets. The ingredients of original drugs and generic drugs are basically the same.